Verification of gastric symptom improvement effect in continuous intake of the lactic acid bacteria

Not Applicable

• Conditions: one

• Registration Number: JPRN-UMIN000042422
• Lead Sponsor: APO PLUS STATION CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-12
• Study Completion: 2022-11-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects undergoing medical institution consultation or treatment for diabetes, digestive disorders eating disorders, and stress-related psychiatric disorders in the last 6 months 2.Subjects who have received drug treatment for dyspepsia symptoms (antacids, secretory inhibitors, prokinetic agents, nonsteroidal anti-inflammatory drugs, aspirin and antidepressants, etc.) in the last 6 months 3.Subjects suspected of being positive for H. pylori or treated for H. pylori eradication 4.Subjects experiencing severe heartburn or acid reflux on screening tests 5.Subjects suspected of having diabetes, dyslipidemia, gastrointestinal disease and severe renal impairment on screening tests 6.Subjects who have been regularly using drugs, quasi-drugs, yogurt, lactic acid bacteria-containing foods, health food nutritional function food, health food, and supplement for the past month or more 7.Subjects who have been using lactic acid foods such as yogurt, lactic acid bacteria beverages, food for specified health use, nutritional functional food, health food, and supplements regularly for the past month or more 8.Subjects with smoking habits 9.Subjects whose normal drinking amount exceeds 1,000 mL (40 g in terms of alcohol) in terms of beer (5%) per day 10.Subjects with food allergies 11.Individuals who are pregnant individuals who plan or want to become pregnant during the study period individuals who are lactating 12.Subjects with bleeding teeth or oral problems (stomatitis, etc.) during saliva test 13.Subjects with large changes in lifestyle 14.Subjects who travel, travel, or travel abroad for more than a week during the study period, or who may or may not 15.Subjects who have participated in other clinical trial in the past one month, who have a plan to participate in other clinical trial during the test period 16.Subjects who are judged as unsuitable for this clinical trial by the investigator for other reasons

Study & Design

• Study Type: Interventional
• Study Design: Not specified